At a glance
ClinicalIndex Comparison RecordPhase 3Recruiting· 40 target
Drug / intervention
Folfox with avastin +1 moredrug
Likely dose
Not stated in record
Key inclusion· 1
- ✓Colorectal cancer stage 4
Key exclusion· 3
- ✕Agranulocytosis
- ✕Pregnancy
- ✕Allergy to mebendazole
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Study Evaluating Mebendazole as Adjuvant Therapy in Patients With Colorectal Cancer
In Brief
A Phase 3 clinical trial evaluating Folfox with avastin and Mebendazole for Colorectal Cancer. Currently recruiting, targeting 40 participants across 1 site.
Detailed Summary
mebendazole treating colon cancer
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsColorectal Cancer
CountriesEgypt
Collaborators--
Timeline
Phase 3Recruiting
20192020202120222023202420252026202720282029
Enrollment StartApr 2019
First PostedApr 2019
TodayJul 2026
Primary CompletionDec 2028
First PostedApr 24, 2019
Enrollment StartApr 1, 2019
Primary CompletionDec 1, 2028
TodayJul 2, 2026
Enrollment to primary: 9.7 yearsPosted 7.2 years agoPrimary completion in 2.4 years
Interventions
Folfox with avastindrug
Folfox with avastin only
Mebendazoledrug
Folfox with avastin with mebendazole